Liraglutide in Spinal Fluid
NCT02104037 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8
Last updated 2014-04-04
Summary
The purpose of this study is to investigate transfer of liraglutide from blood to cerebrospinal fluid.
Conditions
- Liraglutide Blood-brain Transfer
Interventions
- PROCEDURE
-
Lumbar puncture
Sponsors & Collaborators
-
Mikkel Christensen
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2013-12-31
Countries
- Denmark
Study Locations
More Related Trials
-
Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus
NCT01954147 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes
NCT01508923 ·Status: COMPLETED ·Phase: PHASE2
-
Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice
NCT02255266 ·Status: COMPLETED
-
The Use of Liraglutide in Brain Death
NCT03672812 ·Status: COMPLETED ·Phase: PHASE3
-
Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes
NCT06706284 ·Status: RECRUITING ·Phase: PHASE4
-
The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans
NCT02403284 ·Status: COMPLETED ·Phase: PHASE4
-
Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation
NCT02198209 ·Status: WITHDRAWN ·Phase: PHASE4
-
Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes
NCT01509742 ·Status: COMPLETED ·Phase: PHASE1
-
Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes Mellitus
NCT03948347 ·Status: UNKNOWN ·Phase: NA
-
Liraglutide as add-on to Insulin in Type 1 Diabetes
NCT02092896 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 Diabetes
NCT01536665 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients
NCT02655770 ·Status: COMPLETED ·Phase: PHASE4
-
Adding Liraglutide to High Dose Insulin: Breaking the Cycle
NCT01505673 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes
NCT02140983 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Liraglutide in Patients With Prediabetes and Kidney Failure
NCT02284230 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function
NCT02473809 ·Status: COMPLETED ·Phase: PHASE4
-
Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections
NCT02113332 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Liraglutide on Left Ventricular Function in Chronic Heart Failure Patients With and Without Type 2 Diabetes Mellitus
NCT01472640 ·Status: COMPLETED ·Phase: NA
-
Once Weekly GLP-1 in Persons With Spinal Cord Injury
NCT03292315 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients
NCT01761318 ·Status: COMPLETED ·Phase: PHASE4
-
Liraglutide as Additional Treatment in Patients With Type 1 Diabetes Mellitus
NCT01299012 ·Status: COMPLETED
-
Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
NCT01234649 ·Status: COMPLETED ·Phase: PHASE3
-
Liraglutide in the Treatment of Type 1 Diabetes Mellitus
NCT01722266 ·Status: COMPLETED ·Phase: PHASE3
-
Atropin and Glucose Stimulated Insulinsecretion and the Cephalic Insulin Response
NCT01534442 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes
NCT01595789 ·Status: COMPLETED ·Phase: PHASE4